Structural imaging provides a means to visualize change in anatomy associated with cognitive decline (e.g., Project 3 """"""""Attention Profiles in Healthy Aging and Early Stage DAT"""""""") and also candidate surrogate markers for detection of early-stage DAT (e.g., Project 4 """"""""Project 4 """"""""Predicting Cognitive Decline in Healthy Elders""""""""). The goal of the Core F: Neuroimaging is to collect, store, and disseminate imaging data for the use of the present program project investigations and also to facilitate the development of infrastructure to support future imaging projects. The following Specific Aims will be pursued. (1) Structural imaging data on demented and nondemented participants will be collected, in close coordination with Core A: Clinical, at two-year longitudinal intervals. The structural imaging battery will include (i) high-resolution T1-weighted FLASH images for measurement of the hippocampus, (ii) multiple acquisitions of high contrast MP-RAGE images for measurement of cortical atrophy, (iii) FLAIR images for assessment of white-matter, and (iv) diffusion tensor imaging also to assess white-matter integrity. (2) Research neuroradiological assessment will be made by board-certified neuroradiologists on all structural image data sets. (3) Structural data sets will be archived in conjunction with Core D: Biostatistics and made available via a web-based interface to investigators to pursue research projects. (4) Quantitative structural assessment will be provided for correlating imaging data with project-specific data including (i) automated estimates of whole-brain atrophy, (ii) manual estimates of hippocampal, entorhinal, frontal, and other cortical volumes, and (iii) diffusion tensor measures of tissue integrity. (5) Working closely with Core D: Biostatistics and Core E: Administration, data will be managed to integrate the Core's function with the scientific goals of the program project.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-22
Application #
7063460
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
22
Fiscal Year
2005
Total Cost
$211,588
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Liao, Fan; Li, Aimin; Xiong, Monica et al. (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest 128:2144-2155
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Yan, Qi; Nho, Kwangsik; Del-Aguila, Jorge L et al. (2018) Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry :
Islam, Jyoti; Zhang, Yanqing (2018) Brain MRI analysis for Alzheimer's disease diagnosis using an ensemble system of deep convolutional neural networks. Brain Inform 5:2
Strain, Jeremy F; Smith, Robert X; Beaumont, Helen et al. (2018) Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology 91:e313-e318
Roe, Catherine M; Ances, Beau M; Head, Denise et al. (2018) Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain 141:3233-3248
Ogren, Jennifer A; Tripathi, Raghav; Macey, Paul M et al. (2018) Regional cortical thickness changes accompanying generalized tonic-clonic seizures. Neuroimage Clin 20:205-215
Ihara, Ryoko; Vincent, Benjamin D; Baxter, Michael R et al. (2018) Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease. Ann Neurol 84:741-753
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Sutphen, Courtney L; McCue, Lena; Herries, Elizabeth M et al. (2018) Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease. Alzheimers Dement 14:869-879

Showing the most recent 10 out of 911 publications